Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Pancreatic Endocrine Tumor Drug industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Novartis AG
Ipsen SA
Jiangsu Hengrui Medicine Co, Ltd
MediaPharma srl
By Type:
Dovitinib Lactate
MPHE-001B
Fosbretabulin Tromethamine
Others
Buparlisib Hydrochloride
Lanreotide Acetate
By Application:
Hospital
Research Center
Clinic
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Pancreatic Endocrine Tumor Drug Market Overview 2018-2029
-
1.1 China Pancreatic Endocrine Tumor Drug Industry Development Overview
-
1.2 China Pancreatic Endocrine Tumor Drug Industry Development History
-
1.3 China Pancreatic Endocrine Tumor Drug Industry Market Size (2018-2029)
-
1.4 China Pancreatic Endocrine Tumor Drug Market Analysis by Type from Production Side
-
1.4.1 China Pancreatic Endocrine Tumor Drug Production Volume, Production Value and Growth Rate of Dovitinib Lactate (2018-2029)
-
1.4.2 China Pancreatic Endocrine Tumor Drug Production Volume, Production Value and Growth Rate of MPHE-001B (2018-2029)
-
1.4.3 China Pancreatic Endocrine Tumor Drug Production Volume, Production Value and Growth Rate of Fosbretabulin Tromethamine (2018-2029)
-
1.4.4 China Pancreatic Endocrine Tumor Drug Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
1.4.5 China Pancreatic Endocrine Tumor Drug Production Volume, Production Value and Growth Rate of Buparlisib Hydrochloride (2018-2029)
-
1.4.6 China Pancreatic Endocrine Tumor Drug Production Volume, Production Value and Growth Rate of Lanreotide Acetate (2018-2029)
-
1.5 China Pancreatic Endocrine Tumor Drug Market Analysis by Application from Consumption End
-
1.5.1 China Pancreatic Endocrine Tumor Drug Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
1.5.2 China Pancreatic Endocrine Tumor Drug Sales Volume, Sales Value and Growth Rate of Research Center (2018-2029)
-
1.5.3 China Pancreatic Endocrine Tumor Drug Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)
-
1.6 China Pancreatic Endocrine Tumor Drug Market Analysis by Region
-
1.6.1 North China Pancreatic Endocrine Tumor Drug Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Pancreatic Endocrine Tumor Drug Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Pancreatic Endocrine Tumor Drug Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Pancreatic Endocrine Tumor Drug Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Pancreatic Endocrine Tumor Drug Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Pancreatic Endocrine Tumor Drug Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Pancreatic Endocrine Tumor Drug Market Size and Growth Rate from 2018-2029
Chapter 2 China Pancreatic Endocrine Tumor Drug Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Pancreatic Endocrine Tumor Drug Market Status and Competition at home and abroad in 2023
-
2.2.2 China Pancreatic Endocrine Tumor Drug Market Status and Competition Analysis in 2023
-
2.2.3 China Pancreatic Endocrine Tumor Drug Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Pancreatic Endocrine Tumor Drug Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Pancreatic Endocrine Tumor Drug Industry Development
Chapter 3 Pancreatic Endocrine Tumor DrugIndustry Chain Analysis
-
3.1 Pancreatic Endocrine Tumor Drug Industry Chain
-
3.2 Pancreatic Endocrine Tumor Drug Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Pancreatic Endocrine Tumor Drug Market
-
3.3 Pancreatic Endocrine Tumor Drug Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Pancreatic Endocrine Tumor Drug Market
Chapter 4 China Pancreatic Endocrine Tumor Drug Market, by Type
-
4.1 China Pancreatic Endocrine Tumor Drug Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Pancreatic Endocrine Tumor Drug Total Production Volume and Growth Rate from Production Side
-
4.5 China Pancreatic Endocrine Tumor Drug Production Volume and Growth Rate, by Type
-
4.5.1 China Pancreatic Endocrine Tumor Drug Production Volume and Growth Rate of Dovitinib Lactate
-
4.5.2 China Pancreatic Endocrine Tumor Drug Production Volume and Growth Rate of MPHE-001B
-
4.5.3 China Pancreatic Endocrine Tumor Drug Production Volume and Growth Rate of Fosbretabulin Tromethamine
-
4.5.4 China Pancreatic Endocrine Tumor Drug Production Volume and Growth Rate of Others
-
4.5.5 China Pancreatic Endocrine Tumor Drug Production Volume and Growth Rate of Buparlisib Hydrochloride
-
4.5.6 China Pancreatic Endocrine Tumor Drug Production Volume and Growth Rate of Lanreotide Acetate
Chapter 5 China Pancreatic Endocrine Tumor Drug Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Pancreatic Endocrine Tumor Drug Total Market Size and Growth Rate from Consumption End
-
5.5 China Pancreatic Endocrine Tumor Drug Market Size and Growth Rate, by Application
-
5.5.1 China Pancreatic Endocrine Tumor Drug Market Size and Growth Rate of Hospital
-
5.5.2 China Pancreatic Endocrine Tumor Drug Market Size and Growth Rate of Research Center
-
5.5.3 China Pancreatic Endocrine Tumor Drug Market Size and Growth Rate of Clinic
Chapter 6 China Pancreatic Endocrine Tumor Drug Market, by Region
-
6.1 China Pancreatic Endocrine Tumor Drug Production Volume and Production Value, by Region
-
6.2 China Pancreatic Endocrine Tumor Drug Sales Volume and Sales Value, by Region
Chapter 7 North China Pancreatic Endocrine Tumor Drug Market Analysis
-
7.1 North China Pancreatic Endocrine Tumor Drug Market, by Type
-
7.2 North China Pancreatic Endocrine Tumor Drug Market, by Application
Chapter 8 Central China Pancreatic Endocrine Tumor Drug Market Analysis
-
8.1 Central China Pancreatic Endocrine Tumor Drug Market, by Type
-
8.2 Central China Pancreatic Endocrine Tumor Drug Market, by Application
Chapter 9 South China Pancreatic Endocrine Tumor Drug Market Analysis
-
9.1 South China Pancreatic Endocrine Tumor Drug Market, by Type
-
9.2 South China Pancreatic Endocrine Tumor Drug Market, by Application
Chapter 10 East China Pancreatic Endocrine Tumor Drug Market Analysis
-
10.1 East China Pancreatic Endocrine Tumor Drug Market, by Type
-
10.2 East China Pancreatic Endocrine Tumor Drug Market, by Application
Chapter 11 Northeast China Pancreatic Endocrine Tumor Drug Market Analysis
-
11.1 Northeast China Pancreatic Endocrine Tumor Drug Market, by Type
-
11.2 Northeast China Pancreatic Endocrine Tumor Drug Market, by Application
Chapter 12 Southwest China Pancreatic Endocrine Tumor Drug Market Analysis
-
12.1 Southwest China Pancreatic Endocrine Tumor Drug Market, by Type
-
12.2 Southwest China Pancreatic Endocrine Tumor Drug Market, by Application
Chapter 13 Northwest China Pancreatic Endocrine Tumor Drug Market Analysis
-
13.1 Northwest China Pancreatic Endocrine Tumor Drug Market, by Type
-
13.2 Northwest China Pancreatic Endocrine Tumor Drug Market, by Application
Chapter 14 Company Profiles
-
14.1 Novartis AG
-
14.1.1 Novartis AG Company Profile
-
14.1.2 Novartis AG Pancreatic Endocrine Tumor Drug Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Ipsen SA
-
14.2.1 Ipsen SA Company Profile
-
14.2.2 Ipsen SA Pancreatic Endocrine Tumor Drug Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Jiangsu Hengrui Medicine Co, Ltd
-
14.3.1 Jiangsu Hengrui Medicine Co, Ltd Company Profile
-
14.3.2 Jiangsu Hengrui Medicine Co, Ltd Pancreatic Endocrine Tumor Drug Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 MediaPharma srl
-
14.4.1 MediaPharma srl Company Profile
-
14.4.2 MediaPharma srl Pancreatic Endocrine Tumor Drug Market Performance
-
14.4.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Pancreatic Endocrine Tumor Drug Industry Research Conclusions
-
15.2 Pancreatic Endocrine Tumor Drug Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Pancreatic Endocrine Tumor Drug Industry Market Size (2018-2029)
-
Figure China Pancreatic Endocrine Tumor Drug Production Volume, Production Value and Growth Rate of Dovitinib Lactate (2018-2029)
-
Figure China Pancreatic Endocrine Tumor Drug Production Volume, Production Value and Growth Rate of MPHE-001B (2018-2029)
-
Figure China Pancreatic Endocrine Tumor Drug Production Volume, Production Value and Growth Rate of Fosbretabulin Tromethamine (2018-2029)
-
Figure China Pancreatic Endocrine Tumor Drug Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
Figure China Pancreatic Endocrine Tumor Drug Production Volume, Production Value and Growth Rate of Buparlisib Hydrochloride (2018-2029)
-
Figure China Pancreatic Endocrine Tumor Drug Production Volume, Production Value and Growth Rate of Lanreotide Acetate (2018-2029)
-
Figure China Pancreatic Endocrine Tumor Drug Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
Figure China Pancreatic Endocrine Tumor Drug Sales Volume, Sales Value and Growth Rate of Research Center (2018-2029)
-
Figure China Pancreatic Endocrine Tumor Drug Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)
-
Figure North China Pancreatic Endocrine Tumor Drug Market Size and Growth Rate from 2018-2029
-
Figure Central China Pancreatic Endocrine Tumor Drug Market Size and Growth Rate from 2018-2029
-
Figure South China Pancreatic Endocrine Tumor Drug Market Size and Growth Rate from 2018-2029
-
Figure East China Pancreatic Endocrine Tumor Drug Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Pancreatic Endocrine Tumor Drug Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Pancreatic Endocrine Tumor Drug Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Pancreatic Endocrine Tumor Drug Market Size and Growth Rate from 2018-2029
-
Figure Pancreatic Endocrine Tumor Drug Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Pancreatic Endocrine Tumor Drug Market Share by Type in 2018
-
Figure China Pancreatic Endocrine Tumor Drug Market Share by Type in 2023
-
Figure China Pancreatic Endocrine Tumor Drug Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Pancreatic Endocrine Tumor Drug Production Volume and Growth Rate of Dovitinib Lactate (2018-2023)
-
Figure China Pancreatic Endocrine Tumor Drug Production Volume and Growth Rate of MPHE-001B (2018-2023)
-
Figure China Pancreatic Endocrine Tumor Drug Production Volume and Growth Rate of Fosbretabulin Tromethamine (2018-2023)
-
Figure China Pancreatic Endocrine Tumor Drug Production Volume and Growth Rate of Others (2018-2023)
-
Figure China Pancreatic Endocrine Tumor Drug Production Volume and Growth Rate of Buparlisib Hydrochloride (2018-2023)
-
Figure China Pancreatic Endocrine Tumor Drug Production Volume and Growth Rate of Lanreotide Acetate (2018-2023)
-
Figure China Pancreatic Endocrine Tumor Drug Market Share by Application in 2018
-
Figure China Pancreatic Endocrine Tumor Drug Market Share by Application in 2023
-
Figure China Pancreatic Endocrine Tumor Drug Total Market Size and Growth Rate from Consumption End
-
Figure China Pancreatic Endocrine Tumor Drug Market Size and Growth Rate of Hospital (2018-2023)
-
Figure China Pancreatic Endocrine Tumor Drug Market Size and Growth Rate of Research Center (2018-2023)
-
Figure China Pancreatic Endocrine Tumor Drug Market Size and Growth Rate of Clinic (2018-2023)
-
Table China Pancreatic Endocrine Tumor Drug Production Volume by Region (2018-2023)
-
Table China Pancreatic Endocrine Tumor Drug Production Volume Share by Region (2018-2023)
-
Figure China Pancreatic Endocrine Tumor Drug Production Volume Share by Region (2018-2023)
-
Table China Pancreatic Endocrine Tumor Drug Production Value by Region (2018-2023)
-
Table China Pancreatic Endocrine Tumor Drug Production Value Share by Region (2018-2023)
-
Figure China Pancreatic Endocrine Tumor Drug Production Value Share by Region (2018-2023)
-
Table China Pancreatic Endocrine Tumor Drug Sales Volume by Region (2018-2023)
-
Table China Pancreatic Endocrine Tumor Drug Sales Volume Share by Region (2018-2023)
-
Figure China Pancreatic Endocrine Tumor Drug Sales Volume Share by Region (2018-2023)
-
Table China Pancreatic Endocrine Tumor Drug Sales Value by Region (2018-2023)
-
Table China Pancreatic Endocrine Tumor Drug Sales Value Share by Region (2018-2023)
-
Figure China Pancreatic Endocrine Tumor Drug Sales Value Share by Region (2018-2023)
-
Table North China Pancreatic Endocrine Tumor Drug Production Volume by Type (2018-2023)
-
Table North China Pancreatic Endocrine Tumor Drug Production Volume Share by Type (2018-2023)
-
Figure North China Pancreatic Endocrine Tumor Drug Production Volume Share by Type (2018-2023)
-
Table North China Pancreatic Endocrine Tumor Drug Sales Volume by Application (2018-2023)
-
Table North China Pancreatic Endocrine Tumor Drug Sales Volume Share by Application (2018-2023)
-
Figure North China Pancreatic Endocrine Tumor Drug Sales Volume Share by Application (2018-2023)
-
Table Central China Pancreatic Endocrine Tumor Drug Production Volume by Type (2018-2023)
-
Table Central China Pancreatic Endocrine Tumor Drug Production Volume Share by Type (2018-2023)
-
Figure Central China Pancreatic Endocrine Tumor Drug Production Volume Share by Type (2018-2023)
-
Table Central China Pancreatic Endocrine Tumor Drug Sales Volume by Application (2018-2023)
-
Table Central China Pancreatic Endocrine Tumor Drug Sales Volume Share by Application (2018-2023)
-
Figure Central China Pancreatic Endocrine Tumor Drug Sales Volume Share by Application (2018-2023)
-
Table South China Pancreatic Endocrine Tumor Drug Production Volume by Type (2018-2023)
-
Table South China Pancreatic Endocrine Tumor Drug Production Volume Share by Type (2018-2023)
-
Figure South China Pancreatic Endocrine Tumor Drug Production Volume Share by Type (2018-2023)
-
Table South China Pancreatic Endocrine Tumor Drug Sales Volume by Application (2018-2023)
-
Table South China Pancreatic Endocrine Tumor Drug Sales Volume Share by Application (2018-2023)
-
Figure South China Pancreatic Endocrine Tumor Drug Sales Volume Share by Application (2018-2023)
-
Table East China Pancreatic Endocrine Tumor Drug Production Volume by Type (2018-2023)
-
Table East China Pancreatic Endocrine Tumor Drug Production Volume Share by Type (2018-2023)
-
Figure East China Pancreatic Endocrine Tumor Drug Production Volume Share by Type (2018-2023)
-
Table East China Pancreatic Endocrine Tumor Drug Sales Volume by Application (2018-2023)
-
Table East China Pancreatic Endocrine Tumor Drug Sales Volume Share by Application (2018-2023)
-
Figure East China Pancreatic Endocrine Tumor Drug Sales Volume Share by Application (2018-2023)
-
Table Northeast China Pancreatic Endocrine Tumor Drug Production Volume by Type (2018-2023)
-
Table Northeast China Pancreatic Endocrine Tumor Drug Production Volume Share by Type (2018-2023)
-
Figure Northeast China Pancreatic Endocrine Tumor Drug Production Volume Share by Type (2018-2023)
-
Table Northeast China Pancreatic Endocrine Tumor Drug Sales Volume by Application (2018-2023)
-
Table Northeast China Pancreatic Endocrine Tumor Drug Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Pancreatic Endocrine Tumor Drug Sales Volume Share by Application (2018-2023)
-
Table Southwest China Pancreatic Endocrine Tumor Drug Production Volume by Type (2018-2023)
-
Table Southwest China Pancreatic Endocrine Tumor Drug Production Volume Share by Type (2018-2023)
-
Figure Southwest China Pancreatic Endocrine Tumor Drug Production Volume Share by Type (2018-2023)
-
Table Southwest China Pancreatic Endocrine Tumor Drug Sales Volume by Application (2018-2023)
-
Table Southwest China Pancreatic Endocrine Tumor Drug Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Pancreatic Endocrine Tumor Drug Sales Volume Share by Application (2018-2023)
-
Table Northwest China Pancreatic Endocrine Tumor Drug Production Volume by Type (2018-2023)
-
Table Northwest China Pancreatic Endocrine Tumor Drug Production Volume Share by Type (2018-2023)
-
Figure Northwest China Pancreatic Endocrine Tumor Drug Production Volume Share by Type (2018-2023)
-
Table Northwest China Pancreatic Endocrine Tumor Drug Sales Volume by Application (2018-2023)
-
Table Northwest China Pancreatic Endocrine Tumor Drug Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Pancreatic Endocrine Tumor Drug Sales Volume Share by Application (2018-2023)
-
Table Novartis AG Company Profile
-
Table Novartis AG Pancreatic Endocrine Tumor Drug Revenue, Price and Gross (2018-2023)
-
Table Ipsen SA Company Profile
-
Table Ipsen SA Pancreatic Endocrine Tumor Drug Revenue, Price and Gross (2018-2023)
-
Table Jiangsu Hengrui Medicine Co, Ltd Company Profile
-
Table Jiangsu Hengrui Medicine Co, Ltd Pancreatic Endocrine Tumor Drug Revenue, Price and Gross (2018-2023)
-
Table MediaPharma srl Company Profile
-
Table MediaPharma srl Pancreatic Endocrine Tumor Drug Revenue, Price and Gross (2018-2023)
-
